Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biomarker Technologies, widely known as BMKGroup, is a leading high-tech enterprise specializing in genomics services and advanced bioinformatics. Founded in 2009 and headquartered in Beijing, the company provides a comprehensive suite of multi-omics solutions, including next-generation sequencing (NGS), single-cell transcriptomics, spatial genomics, and proteomics. Their proprietary "BioCloud" platform integrates high-performance computing with biological data analysis, enabling researchers to efficiently process and interpret large-scale genomic data. BMKGroup serves a global clientele across the pharmaceutical, agricultural, and academic sectors, facilitating breakthroughs in personalized medicine, drug discovery, and functional genomics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioMarker Group.